Synapse

← Salim Yusuf

Papers by Salim Yusuf

Page 12 · newest first

  1. Cognitive impairment and risk of cardiovascular events and mortalityEuropean Heart Journal · 2012
  2. Designing and Analyzing Clinical Trials with Composite Outcomes: Consideration of Possible Treatment Differences between the Individual OutcomesPLoS ONE · 2012
  3. Blood pressure and other determinants of new-onset atrial fibrillation in patients at high cardiovascular risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease studiesJournal of Hypertension · 2012
  4. The role of comparative effectiveness research in transfusion medicine clinical trials: proceedings of a National Heart, Lung, and Blood Institute workshopTransfusion · 2012
  5. Intracranial Hemorrhage in Atrial Fibrillation Patients During Anticoagulation With Warfarin or DabigatranStroke · 2012
  6. Off-Pump or On-Pump Coronary-Artery Bypass Grafting at 30 DaysNew England Journal of Medicine · 2012
  7. Cardiac Biomarkers Are Associated With an Increased Risk of Stroke and Death in Patients With Atrial FibrillationCirculation · 2012
  8. Increased risk of cognitive and functional decline in patients with atrial fibrillation: results of the ONTARGET and TRANSCEND studiesCanadian Medical Association Journal · 2012
  9. Effect of PON1 Q192R Genetic Polymorphism on Clopidogrel Efficacy and Cardiovascular Events in the Clopidogrel in the Unstable Angina to Prevent Recurrent Events Trial and the Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular EventsCirculation Cardiovascular Genetics · 2012
  10. Homocysteine and Coronary Heart Disease: Meta-analysis of MTHFR Case-Control Studies, Avoiding Publication BiasPLoS Medicine · 2012
  11. Reducing cardiovascular mortality through lifestyle change in JapanEuropean Heart Journal · 2012
  12. Physical activity levels, ownership of goods promoting sedentary behaviour and risk of myocardial infarction: results of the INTERHEART studyEuropean Heart Journal · 2012
  13. Myocardial Ischemic Events in Patients With Atrial Fibrillation Treated With Dabigatran or Warfarin in the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) TrialCirculation · 2012
  14. Marital Status, Education, and Risk of Acute Myocardial Infarction in Mainland China: The INTER-HEART StudyJournal of Epidemiology · 2012
  15. Excess of Rare Variants in Non–Genome-Wide Association Study Candidate Genes in Patients With HypertriglyceridemiaCirculation Cardiovascular Genetics · 2011
  16. The magnetic proximity effect in a ferrimagnetic Fe3O4core/ferrimagnetic γ-Mn2O3shell nanoparticle systemJournal of Physics Condensed Matter · 2011
  17. Urinary Sodium and Potassium Excretion and Risk of Cardiovascular EventsJAMA · 2011
  18. Level of Systolic Blood Pressure Within the Normal Range and Risk of Recurrent StrokeJAMA · 2011
  19. Diffusion of water in molecular magnet Cu0.75Mn0.75[Fe(CN)6]⋅7H2OJournal of Physics Condensed Matter · 2011
  20. The Effect of Chromosome 9p21 Variants on Cardiovascular Disease May Be Modified by Dietary Intake: Evidence from a Case/Control and a Prospective StudyPLoS Medicine · 2011
  21. Blood Pressure Targets Recommended by Guidelines and Incidence of Cardiovascular and Renal Events in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial (ONTARGET)Circulation · 2011
  22. Commentary: 'The end of clinical freedom': relevance in the era of evidence-based medicineInternational Journal of Epidemiology · 2011
  23. Adipocyte Hypertrophy, Fatty Liver and Metabolic Risk Factors in South Asians: The Molecular Study of Health and Risk in Ethnic Groups (mol-SHARE)PLoS ONE · 2011
  24. Effects of Telmisartan on Glucose Levels in People at High Risk for Cardiovascular Disease but Free From DiabetesDiabetes Care · 2011
  25. Changes in Albuminuria Predict Mortality and Morbidity in Patients with Vascular DiseaseJournal of the American Society of Nephrology · 2011
  26. High-Sensitivity Cardiac Troponin I Measurement for Risk Stratification in a Stable High-Risk PopulationClinical Chemistry · 2011
  27. Medical treatment, PCI, or CABG for coronary artery disease?BMJ · 2011
  28. The Fluid Study Protocol: A Randomized Controlled Study on the Effects of Bioimpedance Analysis and Vitamin D on Left Ventricular Mass in Peritoneal Dialysis PatientsPeritoneal Dialysis International · 2011
  29. An Increased Burden of Common and Rare Lipid-Associated Risk Alleles Contributes to the Phenotypic Spectrum of HypertriglyceridemiaArteriosclerosis Thrombosis and Vascular Biology · 2011
  30. Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial FibrillationCirculation · 2011
  31. Glucose levels are associated with cardiovascular disease and death in an international cohort of normal glycaemic and dysglycaemic men and women: the EpiDREAM cohort studyEuropean Journal of Preventive Cardiology · 2011
  32. Impact of transradial and transfemoral coronary interventions on bleeding and net adverse clinical events in acute coronary syndromesEuroIntervention · 2011
  33. Essay for the CIHR/CMAJ award: impact of the Perioperative Ischemic Evaluation (POISE) trialCanadian Medical Association Journal · 2011
  34. Plasma renin activity predicts cardiovascular mortality in the Heart Outcomes Prevention Evaluation (HOPE) studyEuropean Heart Journal · 2011
  35. Cardiovascular and Renal Outcomes With Telmisartan, Ramipril, or Both in People at High Renal RiskCirculation · 2011
  36. Prognostic Value of Troponin and Creatine Kinase Muscle and Brain Isoenzyme Measurement after Noncardiac SurgeryAnesthesiology · 2011
  37. Canadian-led capacity-building in biostatistics and methodology in cardiovascular and diabetes trials: the CANNeCTIN Biostatistics and Methodological Innovation Working GroupTrials · 2011
  38. Apixaban in Patients with Atrial FibrillationNew England Journal of Medicine · 2011
  39. Dabigatran Versus Warfarin in Patients With Atrial FibrillationCirculation · 2011
  40. Efficacy and Safety of Dabigatran vs. Warfarin in Patients With Atrial Fibrillation - Sub-Analysis in Japanese Population in RE-LY Trial -Circulation Journal · 2011
  41. Estimating modifiable coronary heart disease risk in multiple regions of the world: the INTERHEART Modifiable Risk ScoreEuropean Heart Journal · 2010
  42. In a Subgroup of High-Risk Asians, Telmisartan Was Non-Inferior to Ramipril and Better Tolerated in the Prevention of Cardiovascular EventsPLoS ONE · 2010
  43. Environmental Profile of a Community's Health (EPOCH): An Instrument to Measure Environmental Determinants of Cardiovascular Health in Five CountriesPLoS ONE · 2010
  44. Dabigatran and Warfarin in Vitamin K Antagonist–Naive and –Experienced Cohorts With Atrial FibrillationCirculation · 2010
  45. Newly Identified Events in the RE-LY TrialNew England Journal of Medicine · 2010
  46. Cardiovascular disease in India: Lessons learnt & challenges aheadThe Indian Journal of Medical Research · 2010
  47. Effects ofCYP2C19Genotype on Outcomes of Clopidogrel TreatmentNew England Journal of Medicine · 2010
  48. Fine Mapping of the Insulin-Induced Gene 2 Identifies a Variant Associated With LDL Cholesterol and Total Apolipoprotein B LevelsCirculation Cardiovascular Genetics · 2010
  49. Low-Dose vs Standard-Dose Unfractionated Heparin for Percutaneous Coronary Intervention in Acute Coronary Syndromes Treated With Fondaparinux: The FUTURA/OASIS-8 Randomized TrialJAMA · 2010
  50. Mortality predictors and effects of antithrombotic therapies in atrial fibrillation: insights from ACTIVE-WEuropean Heart Journal · 2010